个体化管理未足月胎膜早破以延长潜伏期、降低早产率并改善新生儿结局
这项多中心回顾性研究比较了标准管理与基于羊膜腔穿刺的个体化管理对未足月胎膜早破孕妇的影响。个体化管理组潜伏期>7天比例更高(76.0% vs 41.6%),分娩潜伏期更长(18.1±14.7 vs 9.7±9.7天),<32周早产率更低(72.1% vs 90.5%),新生儿重症监护病房入住率更低(75.6% vs 83.0%),但临床绒毛膜羊膜炎疑似率更高(34.5% vs 22.0%)。
要点
- 个体化管理组潜伏期>7天比例76.0%,标准管理组41.6%(P<.001)。
- 个体化管理组<32周早产率72.1%,标准管理组90.5%(P<.001)。
- 两组组织学绒毛膜羊膜炎、脐带炎及复合感染性母体结局无差异。
核心结论
- 个体化管理可能延长妊娠并降低<32周早产、新生儿支持需求和新生儿重症监护病房入住,且不增加组织学绒毛膜羊膜炎、脐带炎、新生儿感染相关疾病及短期不良母儿结局。
研究设计与样本
- 多中心回顾性研究,纳入2014年至2018年间孕23 0/7至33 6/7周、入院24小时内未分娩的单胎未足月胎膜早破孕妇513例。
- 标准管理组324例来自加拿大Sunnybrook健康科学中心,个体化管理组189例来自西班牙BCNatal(巴塞罗那医院诊所与圣琼德杜医院),采用倾向性评分加权比较。
- 个体化管理组基于入院时羊膜腔穿刺(若可行)排除羊膜腔微生物入侵并给予靶向治疗,其中112例(59.3%)实施了羊膜腔穿刺。
主要发现
- 倾向性评分加权后,个体化管理组潜伏期>7天比例高于标准管理组(76.0% vs 41.6%;P<.001)。
- 个体化管理组分娩潜伏期长于标准管理组(18.1±14.7 vs 9.7±9.7天;P<.001)。
- 个体化管理组临床绒毛膜羊膜炎疑似率高于标准管理组(34.5% vs 22.0%;P<.01)。
- 两组组织学绒毛膜羊膜炎(67.2% vs 73.4%;P=.16)、脐带炎(57.6% vs 58.1%;P=.92)及复合感染性母体结局(9.1% vs 7.9%;P=.64)无差异。
- 个体化管理组<32周早产率低于标准管理组(72.1% vs 90.5%;P<.001),新生儿重症监护病房入住率更低(75.6% vs 83.0%;P=.046),出生后28天需要呼吸支持的比例更低(16.1% vs 26.1%;P<.01),出院时无严重疾病生存率两组无差异(80.4% vs 73.5%;P=.09)。
关键数值与推荐
- 主要结局为潜伏期>7天;次要结局包括分娩潜伏期、绒毛膜羊膜炎及短期不良母儿结局。
- 排除标准为宫颈扩张>2 cm、活跃产程、期待管理禁忌证(急性绒毛膜羊膜炎、胎盘早剥或胎心监护异常)及严重胎儿畸形。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm premature rupture of membranes complicates approximately 3% of pregnancies. Currently, in the absence of chorioamnionitis or placental abruption, expectant management, including antenatal steroids for lung maturation and prophylactic antibiotic treatment, is recommended. The benefits of individualized management have not been adequately explored. OBJECTIVE: This study aimed to compare the impact of 2 different management strategies of preterm premature rupture of membranes in 2 tertiary obstetrical centers on latency of >7 days, latency to birth, chorioamnionitis, funisitis, and short-term adverse maternal and neonatal outcomes. STUDY DESIGN: This was a multicenter retrospective study of women with singleton pregnancies with preterm premature rupture of membranes from 23 0/7 to 33 6/7 weeks of gestation between 2014 and 2018 and undelivered within 24 hours after hospital admission managed at Sunnybrook Health Sciences Center, Toronto, Canada (standard management group), and BCNatal (Hospital Clínic of Barcelona and Hospital Sant Joan de Déu Barcelona), Barcelona, Spain (individualized management group), following local protocols. The standard management group received similar management for all patients, which included a standard antibiotic regimen and routine maternal and fetal surveillance, whereas the individualized management group received personalized management on the basis of amniocentesis at hospital admission (if possible), to rule out microbial invasion of the amniotic cavity and targeted treatment. The exclusion criteria were cervical dilatation >2 cm, active labor, contraindications to expectant management (acute chorioamnionitis, placental abruption, or abnormal fetal tracing), and major fetal anomalies. The primary outcome was latency of >7 days, and the secondary outcomes included latency to birth, chorioamnionitis, and short-term adverse maternal and neonatal outcomes. Statistical comparisons between groups were conducted with propensity score weighting. RESULTS: A total of 513 pregnancies with preterm premature rupture of membranes were included in this study: 324 patients received standard management, and 189 patients received individualized management, wherein amniocentesis was performed in 112 cases (59.3%). After propensity score weighting, patients receiving individualized management had a higher latency of >7 days (76.0% vs 41.6%; P<.001) and latency to birth (18.1±14.7 vs 9.7±9.7 days; P<.001). Although a higher rate of clinical chorioamnionitis was suspected in the individualized management group than the standard group (34.5% vs 22.0%; P<.01), there was no difference between the groups in terms of histologic chorioamnionitis (67.2% vs 73.4%; P=.16), funisitis (57.6% vs 58.1%; P=.92), or composite infectious maternal outcomes (9.1% vs 7.9%; P=.64). Prolonged latency in the individualized management group was associated with a significant reduction of preterm birth at <32 weeks of gestation (72.1% vs 90.5%; P<.001), neonatal intensive care unit admission (75.6% vs 83.0%; P=.046), and neonatal respiratory support at 28 days of life (16.1% vs 26.1%; P<.01) compared with that in the standard management group. Moreover, prolonged latency was not associated with neonatal severe morbidity at discharge (survival without severe morbidity, 80.4% vs 73.5%; P=.09). CONCLUSION: Individualized management of preterm premature rupture of membranes may prolong pregnancy and reduce preterm birth at <32 weeks of gestation, the need for neonatal support, and neonatal intensive care unit admissions, without an increase in histologic chorioamnionitis, funisitis, neonatal infection-related morbidity, and short-term adverse maternal and neonatal outcomes.
引用
- Ronzoni S, Cobo T, D'Souza R, et al. Individualized treatment of preterm premature rupture of membranes to prolong the latency period, reduce the rate of preterm birth, and improve neonatal outcomes. Am J Obstet Gynecol. 2022. PMID: 35257664. doi:10.1016/j.ajog.2022.02.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。